Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Restoring tumor immunogenicity with dendritic cell reprogramming.

Autor: Zimmermannova O; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.; Wallenberg Center for Molecular Medicine at Lund University, BMC A12, 221 84 Lund, Sweden., Ferreira AG; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.; Wallenberg Center for Molecular Medicine at Lund University, BMC A12, 221 84 Lund, Sweden.; CNC-Centre for Neuroscience and Cell Biology, University of Coimbra, Largo Marquês do Pombal, 3004-517 Coimbra, Portugal.; Doctoral Programme in Experimental Biology and Biomedicine, University of Coimbra, Largo Marquês do Pombal, 3004-517 Coimbra, Portugal., Ascic E; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.; Wallenberg Center for Molecular Medicine at Lund University, BMC A12, 221 84 Lund, Sweden., Velasco Santiago M; National Center of Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Borgmester Ib Juuls Vej 1, 2730 Herlev, Denmark., Kurochkin I; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.; Wallenberg Center for Molecular Medicine at Lund University, BMC A12, 221 84 Lund, Sweden., Hansen M; National Center of Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Borgmester Ib Juuls Vej 1, 2730 Herlev, Denmark., Met Ö; National Center of Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Borgmester Ib Juuls Vej 1, 2730 Herlev, Denmark.; Department of Health Technology, Technical University of Denmark, Ørsteds Pl. 345C, 2800 Kongens Lyngby, Denmark., Caiado I; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.; Wallenberg Center for Molecular Medicine at Lund University, BMC A12, 221 84 Lund, Sweden.; CNC-Centre for Neuroscience and Cell Biology, University of Coimbra, Largo Marquês do Pombal, 3004-517 Coimbra, Portugal.; Doctoral Programme in Experimental Biology and Biomedicine, University of Coimbra, Largo Marquês do Pombal, 3004-517 Coimbra, Portugal., Shapiro IE; Ludwig Institute for Cancer Research, Lausanne Branch-University of Lausanne (UNIL), Rue du Bugnon 46, CH-1011 Lausanne, Switzerland.; Department of Oncology-University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Rue du Bugnon 46, CH-1011 Lausanne, Switzerland., Michaux J; Ludwig Institute for Cancer Research, Lausanne Branch-University of Lausanne (UNIL), Rue du Bugnon 46, CH-1011 Lausanne, Switzerland.; Department of Oncology-University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Rue du Bugnon 46, CH-1011 Lausanne, Switzerland., Humbert M; Department of Pathology and Immunology, Geneva Medical School, Av. de Champel 41, 1206 Geneva, Switzerland.; Center for Infectious Medicine, Huddinge Hospital, Karolinska Institutet, Alfred Nobels Allé 8, 141 52 Huddinge, Sweden., Soto-Cabrera D; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.; Wallenberg Center for Molecular Medicine at Lund University, BMC A12, 221 84 Lund, Sweden., Benonisson H; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.; Wallenberg Center for Molecular Medicine at Lund University, BMC A12, 221 84 Lund, Sweden., Silvério-Alves R; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.; Wallenberg Center for Molecular Medicine at Lund University, BMC A12, 221 84 Lund, Sweden.; CNC-Centre for Neuroscience and Cell Biology, University of Coimbra, Largo Marquês do Pombal, 3004-517 Coimbra, Portugal.; Doctoral Programme in Experimental Biology and Biomedicine, University of Coimbra, Largo Marquês do Pombal, 3004-517 Coimbra, Portugal., Gomez-Jimenez D; Department of Immunotechnology, Lund University, Medicon Village, Scheelevägen 2, 223 81 Lund, Sweden., Bernardo C; Division of Oncology, Department of Clinical Sciences, Lund, Medicon Village, Scheelevägen 2, 223 81 Lund, Sweden., Bauden M; Department of Surgery, Clinical Sciences Lund, Lund University, Skåne University Hospital, 221 85 Lund, Sweden., Andersson R; Department of Surgery, Clinical Sciences Lund, Lund University, Skåne University Hospital, 221 85 Lund, Sweden., Höglund M; Division of Oncology, Department of Clinical Sciences, Lund, Medicon Village, Scheelevägen 2, 223 81 Lund, Sweden., Miharada K; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.; International Research Center for Medical Sciences, Kumamoto University, 2-2-1 Honjo, Chuo-Ku, Kumamoto 860-0811, Japan., Nakamura Y; Cell Engineering Division, RIKEN BioResource Research Center, 3-1-1 Koyadai, 305-0074, Tsukuba, Ibaraki, Japan., Hugues S; Department of Pathology and Immunology, Geneva Medical School, Av. de Champel 41, 1206 Geneva, Switzerland., Greiff L; Department of ORL, Head and Neck Surgery, Skåne University Hospital, 221 85 Lund, Sweden.; Department of Clinical Sciences, Lund University, 221 84 Lund, Sweden., Lindstedt M; Department of Immunotechnology, Lund University, Medicon Village, Scheelevägen 2, 223 81 Lund, Sweden., Rosa FF; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.; Wallenberg Center for Molecular Medicine at Lund University, BMC A12, 221 84 Lund, Sweden.; Asgard Therapeutics AB, Medicon Village, 223 81 Lund, Sweden., Pires CF; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.; Wallenberg Center for Molecular Medicine at Lund University, BMC A12, 221 84 Lund, Sweden.; Asgard Therapeutics AB, Medicon Village, 223 81 Lund, Sweden., Bassani-Sternberg M; Ludwig Institute for Cancer Research, Lausanne Branch-University of Lausanne (UNIL), Rue du Bugnon 46, CH-1011 Lausanne, Switzerland.; Department of Oncology-University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Rue du Bugnon 46, CH-1011 Lausanne, Switzerland., Svane IM; National Center of Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Borgmester Ib Juuls Vej 1, 2730 Herlev, Denmark., Pereira CF; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.; Wallenberg Center for Molecular Medicine at Lund University, BMC A12, 221 84 Lund, Sweden.; CNC-Centre for Neuroscience and Cell Biology, University of Coimbra, Largo Marquês do Pombal, 3004-517 Coimbra, Portugal.; Asgard Therapeutics AB, Medicon Village, 223 81 Lund, Sweden.

Publikováno v: Science immunology [Sci Immunol] 2023 Jul 14; Vol. 8 (85), pp. eadd4817. Date of Electronic Publication: 2023 Jul 07.

[Stenocardia and myocardial infarction].

Autor: SHAPIRO IE

Publikováno v: Fel'dsher i akusherka [Feldsher Akush] 1951 May; Vol. 5, pp. 34-9.

[Therapy and prevention of angina pectoris & myocardial infarction].

Autor: SHAPIRO IE

Publikováno v: Fel'dsher i akusherka [Feldsher Akush] 1951 Nov; Vol. 11, pp. 29-34.